Latest Novartis News & Updates

See the latest news and media coverage for Novartis. We track all announcements, press releases, and industry mentions in real time, all in one place.

Novartis

Innovative medicines company

novartis.com

Headquarters: Basel, Switzerland
Company type: Public company
Number of employees: 80,000+

Last updated Today

Latest news about Novartis

In short: Novartis expanded its pipeline and US manufacturing despite first-quarter earnings pressure from generic competition and patent expirations.

Company announcements

June 11 Novartis

Novartis del-brax Phase I/II study meets primary endpoint in FSHD

The FORTITUDE study showed reductions in KHDC1L and creatine kinase levels with a consistent safety profile.

June 8 Novartis

Novartis shows Rhapsido efficacy in chronic inducible urticaria

Phase III RemIND met primary endpoints across three common CIndU subtypes, doubling complete responses versus placebo and supporting FDA sNDA and further global filings in 2026.

June 4 Novartis

Novartis reports Vanrafia slows IgAN kidney decline

Phase III ALIGN (2.5 years) shows ~34% slower eGFR decline and 38% proteinuria reduction; results published in The Lancet and underpin a 2026 approval submission.

June 1 Novartis

Novartis reports positive 144-week Scemblix data in newly diagnosed CML

Scemblix showed 15.2% higher MMR rate vs second-generation TKIs with fewer adverse events, supporting long-term use.

Media coverage

Today Yahoo Finance

Novartis AG (NVS) states Rare Muscle Disease Drug Shows Promise in Early Trial

Novartis AG (NYSE:NVS) is among the Best Pharmaceutical Stocks. On June 11, Novartis AG (NYSE:NVS) reported that an experimental drug acquired through its $12 billion...

Today Fierce Pharma

Whistleblower suit accuses Genentech, Novartis of running decades-long kickback scheme on allergy med Xolair

A newly unsealed whistleblower lawsuit accuses Novartis and Genentech of being at the center of a decades-long kickback scheme to promote their immunology med Xolair...

Today Rediff.com

Novartis Launches Prostate Cancer Radiotherapy

Months after exiting its listed Indian subsidiary, Novartis has reinforced its commitment to the country's innovative ...

June 18 Law360

Patent Claims On Novartis Unit Drug Invalid, Del. Judge Says - Law360

A Delaware federal judge has cleared radiopharmaceutical companies of allegations they infringed claims in various patents owned by a French unit of Novartis after finding...

Never miss news about Novartis

Track Novartis and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Novartis competitors & trending companies

Browse news for competitors to Novartis and other trending companies.